Search for: "In Re Couvaras"
Results 1 - 5
of 5
Sorted by Relevance
|
Sort by Date
27 Jun 2023, 7:32 pm
Noonan -- The Federal Circuit provided a reminder last week that merely identifying an unappreciated consequence of a prior art method cannot confer non-obviousness on practice of methods that did not acknowledge that consequence, in In re Couvaras. [read post]
27 Jun 2023, 7:32 pm
Noonan -- The Federal Circuit provided a reminder last week that merely identifying an unappreciated consequence of a prior art method cannot confer non-obviousness on practice of methods that did not acknowledge that consequence, in In re Couvaras. [read post]
1 Aug 2023, 10:03 am
The Federal Circuit rejected this argument, relying on In re Montgomery, 677 F.3d 1375, 1381 (Fed. [read post]
11 Jul 2023, 7:00 am
While the manner in which the combined drugs achieved the reduction in blood pressure was unforeseen, the Board correctly determined that because the combined drugs yielded the same ultimate outcome as the individual compounds—lowering blood pressure in patients—the novel treatment was not patentable (In re Couvaras, June 14, 2023, Lourie, A.). [read post]
15 Jun 2023, 2:20 pm
By Chris Holman In re Couvaras, 2023 WL 3984753 (Fed. [read post]
